ABMD Annual FCF
$249.63 M
+$28.43 M+12.85%
31 March 2022
Summary:
As of January 22, 2025, ABMD annual free cash flow is $249.63 million, with the most recent change of +$28.43 million (+12.85%) on March 31, 2022. During the last 3 years, it has risen by +$41.43 million (+19.90%).ABMD Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABMD Quarterly FCF
$7.81 M
-$53.51 M-87.26%
30 September 2022
Summary:
As of January 22, 2025, ABMD quarterly free cash flow is $7.81 million, with the most recent change of -$53.51 million (-87.26%) on September 30, 2022. Over the past year, it has dropped by -$45.54 million (-85.36%).ABMD Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABMD TTM FCF
$217.22 M
-$45.54 M-17.33%
30 September 2022
Summary:
As of January 22, 2025, ABMD TTM free cash flow is $217.22 million, with the most recent change of -$45.54 million (-17.33%) on September 30, 2022. Over the past year, it has dropped by -$16.09 million (-6.90%).ABMD TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABMD Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +12.8% | -85.4% | -6.9% |
| 3 y3 years | +19.9% | -87.4% | -15.4% |
| 5 y5 years | +285.8% | -77.9% | -15.4% |
ABMD Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -7.9% | -90.7% | -19.8% |
Abiomed Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | $7.81 M(-87.3%) | $217.22 M(-17.3%) |
| June 2022 | - | $61.32 M(-4.3%) | $262.76 M(+5.3%) |
| Mar 2022 | $249.63 M(+12.9%) | $64.08 M(-23.7%) | $249.63 M(+1.5%) |
| Dec 2021 | - | $84.01 M(+57.5%) | $245.91 M(+5.4%) |
| Sept 2021 | - | $53.35 M(+10.7%) | $233.32 M(-5.8%) |
| June 2021 | - | $48.19 M(-20.2%) | $247.67 M(+12.0%) |
| Mar 2021 | $221.19 M(-18.4%) | $60.37 M(-15.5%) | $221.19 M(-6.6%) |
| Dec 2020 | - | $71.41 M(+5.5%) | $236.88 M(-3.7%) |
| Sept 2020 | - | $67.70 M(+211.8%) | $246.05 M(+2.4%) |
| June 2020 | - | $21.71 M(-71.4%) | $240.25 M(-11.3%) |
| Mar 2020 | $270.91 M(+30.1%) | $76.05 M(-5.6%) | $270.91 M(+5.5%) |
| Dec 2019 | - | $80.59 M(+30.2%) | $256.72 M(+5.8%) |
| Sept 2019 | - | $61.90 M(+18.2%) | $242.63 M(+5.9%) |
| June 2019 | - | $52.38 M(-15.3%) | $229.09 M(+10.0%) |
| Mar 2019 | $208.19 M(+52.3%) | $61.86 M(-7.0%) | $208.19 M(+9.0%) |
| Dec 2018 | - | $66.49 M(+37.5%) | $191.04 M(+23.4%) |
| Sept 2018 | - | $48.36 M(+53.6%) | $154.75 M(+9.2%) |
| June 2018 | - | $31.48 M(-29.6%) | $141.68 M(+3.7%) |
| Mar 2018 | $136.68 M(+111.3%) | $44.70 M(+48.0%) | $136.68 M(+32.9%) |
| Dec 2017 | - | $30.20 M(-14.4%) | $102.86 M(+10.4%) |
| Sept 2017 | - | $35.29 M(+33.2%) | $93.19 M(+33.3%) |
| June 2017 | - | $26.49 M(+143.5%) | $69.91 M(+8.1%) |
| Mar 2017 | $64.70 M(+5.8%) | $10.88 M(-47.0%) | $64.70 M(-5.8%) |
| Dec 2016 | - | $20.54 M(+71.1%) | $68.69 M(-0.5%) |
| Sept 2016 | - | $12.00 M(-43.6%) | $69.02 M(-6.0%) |
| June 2016 | - | $21.28 M(+43.2%) | $73.40 M(+20.0%) |
| Mar 2016 | $61.17 M(+60.5%) | $14.87 M(-28.8%) | $61.17 M(-0.7%) |
| Dec 2015 | - | $20.87 M(+27.4%) | $61.61 M(+11.8%) |
| Sept 2015 | - | $16.39 M(+81.0%) | $55.13 M(+24.3%) |
| June 2015 | - | $9.05 M(-40.9%) | $44.34 M(+16.4%) |
| Mar 2015 | $38.10 M(+84.0%) | $15.31 M(+6.4%) | $38.10 M(+18.2%) |
| Dec 2014 | - | $14.39 M(+157.1%) | $32.23 M(+27.8%) |
| Sept 2014 | - | $5.60 M(+99.1%) | $25.23 M(+4.0%) |
| June 2014 | - | $2.81 M(-70.2%) | $24.26 M(+17.2%) |
| Mar 2014 | $20.70 M(-12.1%) | $9.44 M(+27.8%) | $20.70 M(+14.6%) |
| Dec 2013 | - | $7.38 M(+59.5%) | $18.06 M(+0.7%) |
| Sept 2013 | - | $4.63 M(-722.3%) | $17.94 M(-5.4%) |
| June 2013 | - | -$744.00 K(-111.0%) | $18.97 M(-19.5%) |
| Mar 2013 | $23.56 M(+1147.4%) | $6.79 M(-6.4%) | $23.56 M(+7.3%) |
| Dec 2012 | - | $7.26 M(+28.2%) | $21.95 M(+16.6%) |
| Sept 2012 | - | $5.66 M(+47.1%) | $18.82 M(+27.5%) |
| June 2012 | - | $3.85 M(-25.8%) | $14.77 M(+681.6%) |
| Mar 2012 | $1.89 M(-921.3%) | $5.18 M(+25.5%) | $1.89 M(-148.4%) |
| Dec 2011 | - | $4.13 M(+158.0%) | -$3.90 M(+48.2%) |
| Sept 2011 | - | $1.60 M(-117.7%) | -$2.63 M(-58.4%) |
| June 2011 | - | -$9.03 M(+1394.7%) | -$6.32 M(+2648.7%) |
| Mar 2011 | -$230.00 K(-97.5%) | -$604.00 K(-111.2%) | -$230.00 K(+310.7%) |
| Dec 2010 | - | $5.40 M(-358.4%) | -$56.00 K(-99.0%) |
| Sept 2010 | - | -$2.09 M(-28.8%) | -$5.58 M(-17.4%) |
| June 2010 | - | -$2.94 M(+582.8%) | -$6.75 M(-26.3%) |
| Mar 2010 | -$9.16 M(-58.5%) | -$430.00 K(+258.3%) | -$9.16 M(-11.1%) |
| Dec 2009 | - | -$120.00 K(-96.3%) | -$10.30 M(-25.9%) |
| Sept 2009 | - | -$3.27 M(-38.8%) | -$13.90 M(-6.4%) |
| June 2009 | - | -$5.34 M(+240.2%) | -$14.85 M(-32.7%) |
| Mar 2009 | -$22.06 M(-32.6%) | -$1.57 M(-57.8%) | -$22.06 M(-23.5%) |
| Dec 2008 | - | -$3.72 M(-11.8%) | -$28.83 M(-9.3%) |
| Sept 2008 | - | -$4.22 M(-66.4%) | -$31.79 M(+0.9%) |
| June 2008 | - | -$12.55 M(+50.4%) | -$31.50 M(-3.7%) |
| Mar 2008 | -$32.70 M(+47.0%) | -$8.34 M(+24.8%) | -$32.70 M(+4.9%) |
| Dec 2007 | - | -$6.68 M(+70.3%) | -$31.17 M(+7.4%) |
| Sept 2007 | - | -$3.92 M(-71.5%) | -$29.03 M(-0.7%) |
| June 2007 | - | -$13.75 M(+101.9%) | -$29.24 M(+31.5%) |
| Mar 2007 | -$22.24 M | -$6.81 M(+50.0%) | -$22.24 M(+30.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2006 | - | -$4.54 M(+9.9%) | -$17.11 M(+5.7%) |
| Sept 2006 | - | -$4.13 M(-38.8%) | -$16.19 M(+6.9%) |
| June 2006 | - | -$6.76 M(+301.9%) | -$15.15 M(+22.1%) |
| Mar 2006 | -$12.40 M(+111.6%) | -$1.68 M(-53.5%) | -$12.40 M(+3.1%) |
| Dec 2005 | - | -$3.62 M(+17.0%) | -$12.03 M(+47.6%) |
| Sept 2005 | - | -$3.09 M(-22.9%) | -$8.15 M(+17.4%) |
| June 2005 | - | -$4.01 M(+206.4%) | -$6.94 M(+18.4%) |
| Mar 2005 | -$5.86 M(-44.5%) | -$1.31 M(-597.7%) | -$5.86 M(-22.1%) |
| Dec 2004 | - | $263.00 K(-114.0%) | -$7.52 M(-20.3%) |
| Sept 2004 | - | -$1.89 M(-35.7%) | -$9.43 M(-1.2%) |
| June 2004 | - | -$2.93 M(-1.2%) | -$9.55 M(-9.6%) |
| Mar 2004 | -$10.56 M(-37.9%) | -$2.97 M(+79.8%) | -$10.56 M(-6.2%) |
| Dec 2003 | - | -$1.65 M(-17.6%) | -$11.26 M(-8.9%) |
| Sept 2003 | - | -$2.00 M(-49.3%) | -$12.36 M(-11.2%) |
| June 2003 | - | -$3.95 M(+7.7%) | -$13.91 M(-18.3%) |
| Mar 2003 | -$17.02 M(-19.8%) | -$3.66 M(+33.5%) | -$17.02 M(-15.8%) |
| Dec 2002 | - | -$2.75 M(-22.8%) | -$20.21 M(-11.3%) |
| Sept 2002 | - | -$3.56 M(-49.6%) | -$22.80 M(-5.4%) |
| June 2002 | - | -$7.06 M(+3.0%) | -$24.09 M(+13.5%) |
| Mar 2002 | -$21.24 M(+52.0%) | -$6.85 M(+28.5%) | -$21.24 M(+14.2%) |
| Dec 2001 | - | -$5.33 M(+9.8%) | -$18.60 M(+14.1%) |
| Sept 2001 | - | -$4.86 M(+15.6%) | -$16.30 M(+10.9%) |
| June 2001 | - | -$4.20 M(-0.3%) | -$14.70 M(+5.2%) |
| Mar 2001 | -$13.97 M(+61.3%) | -$4.21 M(+39.1%) | -$13.97 M(+14.3%) |
| Dec 2000 | - | -$3.03 M(-7.0%) | -$12.22 M(+13.2%) |
| Sept 2000 | - | -$3.26 M(-6.3%) | -$10.80 M(+12.2%) |
| June 2000 | - | -$3.48 M(+41.1%) | -$9.62 M(+11.0%) |
| Mar 2000 | -$8.66 M(-3.7%) | -$2.46 M(+54.0%) | -$8.66 M(+5.4%) |
| Dec 1999 | - | -$1.60 M(-23.1%) | -$8.22 M(-5.6%) |
| Sept 1999 | - | -$2.08 M(-17.4%) | -$8.71 M(-0.6%) |
| June 1999 | - | -$2.52 M(+24.9%) | -$8.76 M(-2.7%) |
| Mar 1999 | -$9.00 M(-46.1%) | -$2.02 M(-3.5%) | -$9.00 M(-60.5%) |
| Dec 1998 | - | -$2.09 M(-2.0%) | -$22.78 M(+11.2%) |
| Sept 1998 | - | -$2.13 M(-22.9%) | -$20.49 M(+8.6%) |
| June 1998 | - | -$2.76 M(-82.5%) | -$18.86 M(+13.0%) |
| Mar 1998 | -$16.70 M(+827.8%) | -$15.80 M(-8000.0%) | -$16.70 M(+1307.1%) |
| Dec 1997 | - | $200.00 K(-140.0%) | -$1.19 M(-52.1%) |
| Sept 1997 | - | -$500.00 K(-16.7%) | -$2.48 M(-0.8%) |
| June 1997 | - | -$600.00 K(+109.2%) | -$2.50 M(+38.9%) |
| Mar 1997 | -$1.80 M(-836.8%) | -$286.80 K(-73.8%) | -$1.80 M(+1.0%) |
| Dec 1996 | - | -$1.09 M(+110.2%) | -$1.78 M(+526.0%) |
| Sept 1996 | - | -$520.00 K(-620.0%) | -$284.60 K(-312.9%) |
| June 1996 | - | $100.00 K(-137.2%) | $133.70 K(-45.3%) |
| Mar 1996 | $244.30 K(-69.5%) | -$268.50 K(-166.5%) | $244.30 K(-84.9%) |
| Dec 1995 | - | $403.90 K(-497.1%) | $1.61 M(+6.9%) |
| Sept 1995 | - | -$101.70 K(-148.3%) | $1.51 M(-37.4%) |
| June 1995 | - | $210.60 K(-80.9%) | $2.41 M(+167.8%) |
| Mar 1995 | $800.00 K(-122.2%) | $1.10 M(+266.7%) | $900.00 K(-181.8%) |
| Dec 1994 | - | $300.00 K(-62.5%) | -$1.10 M(-35.3%) |
| Sept 1994 | - | $800.00 K(-161.5%) | -$1.70 M(-54.1%) |
| June 1994 | - | -$1.30 M(+44.4%) | -$3.70 M(+2.8%) |
| Mar 1994 | -$3.60 M(-21.7%) | -$900.00 K(+200.0%) | -$3.60 M(+2.9%) |
| Dec 1993 | - | -$300.00 K(-75.0%) | -$3.50 M(-20.5%) |
| Sept 1993 | - | -$1.20 M(0.0%) | -$4.40 M(0.0%) |
| June 1993 | - | -$1.20 M(+50.0%) | -$4.40 M(-4.3%) |
| Mar 1993 | -$4.60 M(+31.4%) | -$800.00 K(-33.3%) | -$4.60 M(+2.2%) |
| Dec 1992 | - | -$1.20 M(0.0%) | -$4.50 M(+4.7%) |
| Sept 1992 | - | -$1.20 M(-14.3%) | -$4.30 M(+22.9%) |
| June 1992 | - | -$1.40 M(+100.0%) | -$3.50 M(+2.9%) |
| Mar 1992 | -$3.50 M(-16.7%) | -$700.00 K(-30.0%) | -$3.40 M(+25.9%) |
| Dec 1991 | - | -$1.00 M(+150.0%) | -$2.70 M(+58.8%) |
| Sept 1991 | - | -$400.00 K(-69.2%) | -$1.70 M(+30.8%) |
| June 1991 | - | -$1.30 M | -$1.30 M |
| Mar 1991 | -$4.20 M | - | - |
FAQ
- What is Abiomed annual free cash flow?
- What is the all time high annual FCF for Abiomed?
- What is Abiomed annual FCF year-on-year change?
- What is Abiomed quarterly free cash flow?
- What is the all time high quarterly FCF for Abiomed?
- What is Abiomed quarterly FCF year-on-year change?
- What is Abiomed TTM free cash flow?
- What is the all time high TTM FCF for Abiomed?
- What is Abiomed TTM FCF year-on-year change?
What is Abiomed annual free cash flow?
The current annual FCF of ABMD is $249.63 M
What is the all time high annual FCF for Abiomed?
Abiomed all-time high annual free cash flow is $270.91 M
What is Abiomed annual FCF year-on-year change?
Over the past year, ABMD annual free cash flow has changed by +$28.43 M (+12.85%)
What is Abiomed quarterly free cash flow?
The current quarterly FCF of ABMD is $7.81 M
What is the all time high quarterly FCF for Abiomed?
Abiomed all-time high quarterly free cash flow is $84.01 M
What is Abiomed quarterly FCF year-on-year change?
Over the past year, ABMD quarterly free cash flow has changed by -$45.54 M (-85.36%)
What is Abiomed TTM free cash flow?
The current TTM FCF of ABMD is $217.22 M
What is the all time high TTM FCF for Abiomed?
Abiomed all-time high TTM free cash flow is $270.91 M
What is Abiomed TTM FCF year-on-year change?
Over the past year, ABMD TTM free cash flow has changed by -$16.09 M (-6.90%)